2-Year Follow-up: Association of Peripheral Arterial Disease, Albuminuria, Dyslipidemia with HbA1c in T2DM Patients

被引：0
|
作者：
Rohatgi, R. [1 ]
Kudkar, P. [1 ]
Alfred, D. [1 ]
机构：
[1] Rohit Diabet Ctr, Diabet, Mumbai, Maharashtra, India
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2024年 / 209卷
关键词：
D O I：
10.1016/j.diabres.2024.111391
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
IDF23-0568
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Efficacy and Safety of Empagliflozin (EMPA) in Younger, Overweight/Obese Patients with Type 2 Diabetes (T2DM) with HbA1c ≥8%
    Merker, Ludwig
    Lund, Soren S.
    Hantel, Stefan
    Salsali, Afshin
    Kim, Gabriel
    Broedl, Uli C.
    Woerle, Hans J.
    Hach, Thomas
    DIABETES, 2014, 63 : A280 - A281
  • [42] A 2-year follow-up study of patients with pharyngotonsillitis
    Jon Pallon
    Martin Sundqvist
    Katarina Hedin
    BMC Infectious Diseases, 18
  • [43] IMPACT OF DIGITAL THERAPEUTICS ON HBA1C AND DRUG COMPLIANCE IN T2DM PATIENT OF CENTRAL INDIA
    Saboo, B.
    Saboo, S.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A121 - A121
  • [44] A 2-YEAR FOLLOW-UP STUDY OF ALCOHOLIC PATIENTS
    RATHOD, NH
    GREGORY, E
    BLOWS, D
    THOMAS, GH
    BRITISH JOURNAL OF PSYCHIATRY, 1966, 112 (488) : 683 - &
  • [45] 2-Year Mean HbA1c Is Not Associated with Increased Arterial Stiffness in Youth with Type 1 Diabetes
    Cruz, Eric R.
    Maahs, David M.
    Bishop, Franziska K.
    Klingensmih, Georgeanna J.
    Wadwa, R. Paul
    DIABETES, 2009, 58 : A456 - A457
  • [46] A 2-year follow-up study of patients with pharyngotonsillitis
    Pallon, Jon
    Sundqvist, Martin
    Hedin, Katarina
    BMC INFECTIOUS DISEASES, 2018, 18
  • [47] Durability of Dapagliflozin Treatment Response in Patients With T2DM: 2-Year Results
    Salsali, Afshin
    Rohwedder, Katja
    Mansfield, Traci
    Martin, Paula
    Wei, Li
    Parikh, Shamik
    DIABETES, 2012, 61 : A264 - A264
  • [48] REHABILITATION OF IMPAIRED PHYSICIANS - 1-YEAR FOLLOW-UP AND 2-YEAR FOLLOW-UP
    HERRINGTON, RE
    BENZER, DG
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1981, 5 (01) : 153 - 153
  • [49] THE IMPORTANCE OF HBA1C EVOLUTION IN COST-EFFECTIVENESS MODELING OF TYPE 2 DIABETES MELLITUS (T2DM)
    Willis, M.
    He, J.
    Neslusan, C.
    Johansen, P.
    Worbes-cerezo, M.
    VALUE IN HEALTH, 2012, 15 (07) : A500 - A500
  • [50] Implications of Using the UKPDS HbA1c Equation in Economic Modeling of Type 2 Diabetes Mellitus (T2DM)
    Willis, Michael
    Asseburg, Christian
    Johansen, Pierre
    Schroeder, Melanie
    Neslusan, Cheryl
    DIABETES, 2016, 65 : A581 - A581
12345